MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term marketable
securities
$625,170K
Cash and cash
equivalents
$241,208K
Prepaid expenses and
other current assets
$11,425K
Total current assets
$877,803K
Operating lease,
right-of-use assets
$17,549K
Property and equipment,
net
$5,298K
Other assets
$1,940K
Restricted cash
$416K
Total assets
$903,006K
Total liabilities and
stockholders equity
$903,006K
Total stockholders
equity
$607,693K
Total liabilities
$295,313K
Accumulated deficit
-$1,285,772K
Accumulated other
comprehensive income (loss)
-$415K
Additional paid-in capital
$1,828,956K
Convertible senior notes,
net
$223,173K
Total current
liabilities
$57,981K
Operating lease
liabilities, net of current...
$14,097K
Other liabilities
$62K
Preferred stock,
value-Series BNon Voting...
$35,563K
Preferred stock,
value-Series ANon Voting...
$29,190K
Common stock, 0.001 par
value 300,000,000...
$171K
Accrued expenses and
other current...
$42,854K
Accounts payable
$13,744K
Operating lease
liabilities
$1,383K
Back
Back
Balance Sheet
source: myfinsight.com
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT)